Mission Hosts
The New Jerusalem Foundation
The Jerusalem Development Authority
Mr. Ehud Olmert - Vice Prime Minister and Minister of Industry, Labor & Trade, State of Israel
Mr. Danny Naveh - Minister of Health, State of Israel
Mr. Uri Lupolianski - Mayor of Jerusalem

Chair People
Jonathan Silverstein, General Partner, OrbiMed Advisors, LLC
Isaac Applbaum, Partner & Managing Director, Israel, Lightspeed Ventures
Dr. Martin Leon, Associate Director, Cardiovascular Interventional Therapy (CIVT); Chairman, Cardiovascular Research Foundation; and Professor of Medicine at New York Presbyterian/Columbia University Medical Center
Mark Minevich, Chair, Global Leadership Council & International Strategic Adviser, Going Global Ventures Inc.
Mark Simon, Managing Director and Head of Biotechnology, Citigroup
Michael Vasinkevich, Senior Managing Director, Rodman and Renshaw, LLC

Advisory Board
Prof. Haim Aviv, Chairman and CEO, Pharmos
Yehuda Baruch M.D. M.H.A, Director General , Abarabanel Psychiatric Center, Advisor to the Director General, Ministry of Health
Dr. Ronit Bendori, General Partner, Ever Green Venture Partners
Prof Rafael Beyar MD DSc, Director, Division of Invasive Cardiology, Rambam Medical Center; Women's Division / Dr. Phillip and Sarah Gotlieb Professor in Medicine and Biomedical Engineering, Technion
Nava Swersky Sofer, Partner, Concord Ventures
Neil Cohen, Partner Israeli Seed
Batsheva Elran, Managing Partner, Medica Venture Partners
Dr. Ehud Geller, Founder and Managing Partner, Medica Venture Partners
Dr. Raphael Hofstein, President and CEO, Hadasit, Medical Research Services & Development
Dr. Shlomo Kalish, Founding Partner, Jerusalem Global Ventures
Dr. Avi Molcho, Managing Director, Giza Venture Capital
Dr. Hadar Ron, Managing Director, Israel Health Care Ventures
Mr. Rafi Sela, President, AR Challenges Ltd.
Dr. Benny Zeevi, General Partner, Tamir Fishman

Participants
Isaac Applbaum, Partner & Managing Director, Israel, Lightspeed Ventures
Dr. Sol J. Barer, Ph.D., President/COO, Celgene Corporation
Dr. Alex Barkas, Ph.D., Managing Director, Prospect Venture Partners
Marina Bozilenko, Senior Managing Director, Bearn Stearns’
Joseph Cerro, Head of Informatics Research, Bayer Pharmaceuticals Corporation
Alison de Bord, Principal, Alta Partners
Richard A. Edlin, Principal Shareholder, Greenberg Traurig, LLP
Tal Fuhrer, Global Business Development, Wyeth Consumer Healthcare
Robert L. Garnick, Ph.D., Senior Vice President, Regulatory, Quality and Compliance, Genentech, Inc.
Robert H. Glassman, M.D., Director, Healthcare Investment Banking, Mergers & Acquisitions Group, Merrill Lynch, Inc.
Barry Greene, Chief Operating Officer, Alnylam Pharmaceuticals, Inc.
Bob Grossman, Principal Shareholder and Co-Chair of Israeli Practice Group, Greenberg Traurig, LLP
Hans Peter Hasler, Senior Vice President, Head of International, Biogen Idec, Inc.
Tamar Howson, Senior Vice President, Corporate & Business Development, Bristol-Myers Squibb Company
Leonard Kruimer, Vice President, Chief Financial Officer, Crucell
Dr. Jeremy Levin, Global Head of Strategic Alliances, Novartis Institutes for BioMedical Research, Inc.
Terry McGuire, Managing Partner, Polaris Venture Partners
Mark Minevich, Chair, Global Leadership Council & International Strategic Adviser, Going Global Ventures Inc.
Tim C. Opler, Managing Director, Health Care, Credit Suisse First Boston
Mark Pruzanski, M.D., President & CEO, Intercept Pharmaceuticals
Thomas Redigton, President, Redigton, Inc.
Leonard Shaykin, Chairman and CEO, Tapestry Pharmaceuticals, Inc.
Jonathan Silverstein, General Partner, OrbiMed Advisors, LLC
Mark Simon, Managing Director and Head of Biotechnology, Citigroup
Jean-Pierre Sommadossi, Chairman and CEO, Idenix Pharmaceuticals, Inc.
Roger G. Stoll, Ph.D., President and Chief Executive Officer, Cortex Pharmaceuticals, Inc.
Jeff R. Swarz, Ph.D., Managing Director, Life Science Group
Michael Vasinkevich, Senior Managing Director, Rodman and Renshaw, LLC



Back to Top